Dr. Landis is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He truly enjoys the challenge of caring for cancer patients. A diagnosis of cancer can be overwhelming for a patient and their family. From the beginning he will review the diagnosis in detail, the treatment options, and the potential results of each option, including possible side effects. Dr. Landis enjoys seeing his patients over time, during the course of treatment, and in follow-up. Often it takes some time to understand the patients priorities and wishes. As a physician, he believes in prioritizing the patients quality of life and listening to understand their desires and incorporate this into an individualized treatment plan. He strives to provide the best possible care to all of his patients. Dr. Landis is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Nasopharyngeal Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor.

More people survive cancer now than ever before. I see my role as being a strong advocate for my patients, fully informing them of their options and supporting them throughout their treatment programs. Dr. Fer is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

Dr. Bonm strives to partner with his patients, ensure they are well-informed regarding their options, and decide among those options together. He aims to simplify care for his patients by attending to both their neurologic and their oncologic needs. His goal is to get to know each patient and their families, in order to be able to deliver personalized care in a manner that is consistent with their needs, desires, and values. Dr. Bonm is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Brain Tumor, Glioma, Embryonal Tumor with Multilayered Rosettes, and Glioblastoma.

Physicians have the great privilege of being entrusted to guide patients on a path to better health. Oncologists have the difficult task of rendering therapies which can add years of life but may take from the quality of those years. My desire to add quality and years to my patients lives is what drives me to do cancer research. Dr. Meier is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Meier is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Muscle Invasive Bladder Cancer.

Dr. Takamiya is an experienced radiation oncologist that has been an integral part of the Swedish Cancer Institute since 2004. Serving as the medical director of Radiation Oncology at Edmonds since 2005, he has been an integral part of the Edmonds Cancer Committee, holding positions such as a physician member, cancer liaison physician and chair since 2008. Dr. Takamiya joined the Seattle Prostate Institute at Swedish, which pioneered LDR prostate brachytherapy. There, he was the director education, training other physicians across the globe. He is an expert in prostate brachytherapy, as well as high risk prostate cancer. He has brought new oncologic therapies to Swedish Edmonds, including novel radiopharmaceuticals. Areas of clinical interest include brain tumors, head and neck cancer, lung, breast, and GI malignancies. Recognized for his exceptional dedication to his patients and his field, Dr. Takamiya is a multiple recipient of the Seattle Top Doctor Award, and most recently, he was honored with the Seattle Met 2023 Top Doc Award. With an unwavering commitment to excellent patient care, Dr. Takamiya delivers personalized cancer care right in the heart of Edmonds. Through the Swedish Cancer Institute, patients not only received top-tier treatment but also gain access to advanced treatments therapies, comprehensive support, and the expertise of a world-class cancer institute. This ensures that patients receive the best care possible while being close to home. This is very important to Dr. Takamiya, who himself is a member of this community. Dr. Takamiya is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

Dr. Fang is a distinguished radiation oncologist with expertise in treating various cancers including breast, brain, lung, and more. She completed her radiation oncology residency at the University of Washington and a fellowship at MD Anderson Cancer Center. With over a decade of experience at the University of Washington and Fred Hutch Cancer Center, she joined the Swedish Cancer Institute in 2022. As an Associate Professor at the University of Washington, Dr. Fang significantly contributed to multi-institutional clinical trials, trained residents, and served on key committees. Her innovative work in proton therapy for breast cancer has earned her national recognition. Known for her compassionate care, Dr. Fang adopts an evidence-based, personalized approach to ensure her patients receive the highest quality of care. She emphasizes patient understanding and empowerment, helping them make informed decisions. Dr. Fang’s dedication and patient-centric approach make her a valued collaborator in her patients’ healthcare journeys. Dr. Fang is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Breast Cancer, Angiosarcoma, Glioma, and Brain Tumor.

Meng Zhao, MD, PhD, joined Providence Swedish in July 2020. She received her medical degree from the Tongji University School of Medicine in Shanghai, China. Dr. Zhao completed an Internal Medicine Residency at the University of Texas Southwestern Medical Center, and then went on to study Oncology and Hematology at The Ohio State University Comprehensive Cancer Center and Wexner Medical Center in Columbus, OH. She is board certified by the American Board of Medical Oncology, and the American Board of Hematology. She is also a member of the American Society of Clinical Oncology. She earned a PhD in Cell and Molecular Biology at the University of Texas at Austin in Austin, TX. Philosophy of Care: Dr. Zhao focuses on personalized care and shared decision-making. She engages in open dialogues with patients and their families to discuss diagnoses and treatment options. Dr. Zhao blends clinical excellence with compassion and empathy. Her mission is to enhance the outcomes and quality of life for cancer patients and their families throughout their journey. Dr. Zhao, a skilled clinical researcher, previously held the role of clinical research director and principal investigator for diverse clinical trials. Now, in Swedish Cancer Institute, she continues her cancer research journey, benefiting patients with a robust clinical trials program and cutting-edge treatments. Dr. Zhao is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Pleuropulmonary Blastoma, Neonatal Onset Multisystem Inflammatory Disease, and Lung Cancer.

Dr. Lopez believes in providing holistic care to his patients which includes the treatment of their medical diagnosis, as well as their social and emotional needs. Dr. Lopez is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Angiosarcoma.

"Dr. Paulson is passionate about practicing medical oncology, as it seamlessly integrates cutting-edge scientific advancements with the compassionate essence of medicine. Her clinical interests focus on skin cancer and solid tumor immunotherapy while Dr. Paulson’s appreciation lies in the ability to establish meaningful connections with patients and their families, throughout their care. Dr. Paulson firmly believes that optimal cancer care is achieved through a collaborative, team-based approach and takes great joy in working alongside an interdisciplinary team of dedicated healthcare professionals. Recognizing the pivotal role of patients in their own care, she is committed to transparent communication, ensuring that everyone understands the ""how and why"" behind their personalized treatment plans. In addition to her clinical role, Dr. Paulson is a skilled clinical researcher, serving as the Principal Investigator for various clinical trials aimed at bringing the latest advancements in cancer care and the lead for the Center for Immuno-Oncology at the Paul G Allen Research Center. Furthermore, she is dedicated to nurturing the next generation of medical professionals, actively supporting medical students at the Washington State University Elson E. Floyd Medical School in Everett, particularly in advancing their understanding of emerging immunotherapies. In 2023, Dr. Kelly Paulson was honored as the inaugural recipient of the Jeff Ward Award, established to memorialize him. This distinguished award acknowledges medical staff members who contribute positively to the Edmonds community through exceptional leadership, mentorship, or improvements in patient care. Also, she is a 2024 Castle Connolly Top Doctor. Dr. Paulson sees patients at the Edmonds and First Hill Swedish Cancer Institute locations.". Dr. Paulson is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Merkel Cell Carcinoma, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Colorectal Cancer.

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Nerve Decompression.

"Dr. Fengting Yan is a 2021, 2022, & 2023 Seattle Met Top Doctor Award winner. Dr. Yan is interested in personalized care and translational research in women’s cancer. Extensive lab and clinical research knowledge are applied in her ""bench-to-bedside"" approach to patient care. Dr. Yan also has years of experience in public education on women’s health through internet and TV talk shows.". Dr. Yan is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Inflammatory Breast Cancer.

Dr. Mehta is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. He enjoys working with patients and family members. There are a wide variety of treatment options available for nearly every patient, so it is important to spend as much time as is needed in order to weight the benefits and risks to any particular approach. He feels that it is important that communication is open and honest. The goals of treatment, whether it is going for cure or maximizing quality of life should be openly discussed and re-discussed as the need arises. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Anal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Todd Barnett is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Barnett earned his medical degree from Northwestern University, Chicago, Ill. He completed his residency and fellowship at Stanford University, Calif. Dr. Barnett is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Familial Pancreatic Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Follicular Thyroid Cancer.

Dr. Patel is a neurosurgeon at the Swedish Neuroscience Institute. His philosophy of care is to provide comprehensive care and superior service in order to help and change the lives of his patients for the better. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Brain Aneurysm, Stroke, Subdural Hematoma, Cerebral Artery Bypass Surgery, and Extracranial-Intracranial Bypass Surgery.

Dr. Monteith's philosophy of care is to approach the care of each of his patients as if they were a member of his own family. He strives to give his patients the best possible outcome by combining the latest technological advances with personalized clinical care. When possible, he uses endovascular or minimally invasive surgical approaches, so that his patients can recover from their procedure and get back to their normal lives as soon as possible. Dr. Monteith is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Brain Aneurysm, Congenital Cardiovascular Shunt, Normal Pressure Hydrocephalus, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery.

Dr. Litvack values a collaborative multi-disciplinary approach to caring for patients suffering from benign or malignant brain tumors, head and neck cancers involving the brain and spine, chronic pain and degenerative spinal disorders. Dr. Litvack applies his unique expertise in skull base surgery, neuroendoscopy, minimally invasive cranial, and minimally invasive spinal surgery to restore patients to health while minimizing the physical and emotional impact of surgery. His patients benefit from being fully informed of their disease and their treatment options. Dr. Litvack and his patients also benefit from 24/7 access to a team of fellowship-trained physicians and surgeons with extensive experience in Neurosurgery, Otolaryngology, Neuroanesthesia, Neuro-endocrinology, Neuro-ophthalmology, Neuro-Oncology and Radiation Oncology. Dr. Litvack has also been selected by Seattle Magazine and Seattle Metropolitan Magazine as a Top Doctor in the field of Neurosurgery. Dr. Litvack is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Pituitary Tumor, Prolactinoma, Hypothalamic Tumor, Balloon Sinuplasty, and Awake Craniotomy.

Dr. Michael Doherty is a Neurologist who specializes in Epilepsy care. He joined the Swedish Neuroscience Institute in 2003 and is the Medical Director of our Epilepsy program. Dr. Doherty works closely with Swedish’s multidisciplinary epilepsy team on state of the art therapies. Specific interests include special needs populations, medication management during pregnancy, new onset seizure, hard-to-treat epilepsy and neurostimulation or surgical treatments of epilepsy. Dr. Doherty was selected by Seattle Magazine as a Top Doctor. Dr. Doherty is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Seizures, Memory Loss, Epilepsy, Knee Replacement, and Hip Replacement.

Subhash Sharma is a Hematologist Oncology specialist and a Hematologist in Mukilteo, Washington. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Sharma is currently accepting new patients.

Dr. Norman is board-certified in Internal Medicine, Hematology and Oncology. With twenty years of practice experience, Dr. Norman is well prepared to provide your care. He is person centered-providing the best care based upon national guidelines, but tailored to your specific needs. Dr. Norman is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Anal Cancer, Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), and Small Cell Lung Cancer (SCLC).

Huong Pham, MD, is a board-certified radiation oncologist with special interest in brain tumors, radiosurgery, breast cancer, prostate cancer and brachytherapy.Dr. Pham strives to be accessible to her patients, welcoming their questions and concerns. In collaboration with her multidisciplinary team, she does everything in her power to give her patients the highest quality, safest and most accurate treatment available.Away from work, Dr. Pham enjoys spending time with her family and playing sports including tennis, snowboarding and surfing. Dr. Pham is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Radiation Induced Meningioma, Meningioma, Familial Prostate Cancer, and Posterior Fossa Tumor.